Refine
Year of publication
- 2023 (1)
Document Type
- Doctoral Thesis (1)
Language
- English (1)
Has Fulltext
- yes (1)
Is part of the Bibliography
- no (1)
Institute
- Institut für Mathematik und Informatik (1) (remove)
Tafazzin is an acyltransferase with key functions in remodeling of the mitochondrial phospholipid cardiolipin (CL) by exchanging single fatty acids species in CL. Tafazzin-mediated CL remodeling determines the actual CL compositions and has been implicated in mitochondrial morphology and function. Thus, any deficiency of tafazzin leads to altered fatty acid composition of CL which is directly associated with impaired mitochondrial respiration and ATP production. Mutations in the tafazzin encoding gene TAZ, are the cause of the severe X-linked genetic disease, BARTH syndrome (BTHS).
Previous work provided first hints on a linkage of CL composition and subsequent limitations in the cellular ATP levels which may contribute to the restriction of growth. However, in C6 cells ATP levels remained unaltered due to compensatory activation of glycolysis. Moreover, it has been demonstrated that the substantial changes in CL composition are similarly resulting from knocking down either cardiolipin synthase (CRLS) or TAZ. This has also been shown in C6 glioma cells. Most notably only the knock down of TAZ, but not that of CRLS, compromised proliferation of C6 glioma cells. Therefore, a CL- independent role of TAZ in regulating cell proliferation is postulated.
In this study, any linkage of the lack of tafazzin to cellular proliferation should be investigated in more detail to allow first insight into underlying mechanisms.
The results of the current study demonstrate that the tafazzin knockout in C6 glioma cells show changes in global gene expression by applying transcriptome analysis using the- microarray Clarion S rat Affymetrix array. Out of 22,076 total number of genes detected, 1,099 genes were differentially expressed in C6 knockout cells which were either ≥2 and ≥4 fold up or down regulated genes. Furthermore, expression of selected target genes was validated using RT-qPCR. We have hypothesised that the changes in TAZ dependent gene expression is via PPAR transcription factor. According to eukaryotic promoter database (EPD) for selected target genes, exhibited at least one putative binding site for PPARG and PPARA transcription factors. However, pioglitazone and LG100268, synthetic ligands of PPARG and RXR, could not show any effect on changes in gene expression in C6 TAZ cells. Another class of cellular lipids, oxylipins were found to occur in significantly higher amounts in C6 TAZ cells compared to C6 cells which makes them candidates for mediating cellular effects and regulating gene expression via PPARs. A computational tool CiiiDER was used to for the prediction of transcription factor binding site. The transcription factors enriched in TAZ- regulated genes were found to be HOXA5 and PAX2, binding sites of which could be detected in 100 % of TAZ- regulated genes (>2-fold). By applying IPA to the differentially expressed genes we could identify lipid metabolism, and cholesterol superpathway in particular as the most affected pathway in C6 TAZ cells. This pathway consists of 20 genes, of which all (20/20) appeared to be differentially regulated in C6 TAZ cells. Of all the 20 genes, 4 of the differentially expressed genes were selected for further validation by RT-qPCR. By IPA it was possible to identify the upstream regulators that might be responsible for the differential expression of genes in C6 deficient cells. Some of the genes ACACA, HMGCR, FASN, ACSL1, 3 and, 5 identified was decreased by predicted activation and inhibition of the regulators. Further we have analysed the levels of cellular cholesterol content in C6 and C6 TAZ (w/o Δ5 and FL) cells. In C6 cells cholesterol is present more in its free form. C6 TAZ cells have increased amount of cholesterol compared to C6 cells. However, Δ5 and FL expressed C6 TAZ cells showed less amount of cholesterol.
Previous work established that knockout of tafazzin in C6 cells showed decreased cell proliferation in the absence of any changes in ATP content. To understand this phenomenon cellular senescence associated β-galactosidase in C6 and C6 TAZ cells was performed. C6 TAZ cells showed increased percentage of β-gal positive cells compared to C6 cells. Moreover, senescent associated secretory phenotype (SASP) represented by e.g. CXCL1, IL6, and IL1α was determined using RT-qPCR. Gene expression of these SASP factors was significantly upregulated in C6 TAZ cells.
Several human tafazzin isoforms exists due to alternate splicing. However, whether these isoforms differ in function and in CL remodelling activity or specificity, in particular, is unknown. The purpose of this work was to determine if specific isoforms, such as human isoform lacking exon 5 (Δ5), rat full length tafazzin (FL) and enzymatically dead full length tafazzin (H69L), can restore the wild type phenotype in terms of CL composition, cellular proliferation, and gene expression profile. Therefore, in the second part, it was demonstrated that expression of Δ5 to some extent and rat full length tafazzin can completely restore CL composition, in C6 TAZ cells which is naturally linked to the restoration of mitochondrial respiration. As expected, a comparable restoration of CL composition could not be seen after re-expressing an enzymatically dead full-length rat TAZ, (H69L; TAZ Mut). Furthermore, re-expression of the TAZ Mut largely failed to reverse the alterations in gene expression, in contrast re-expression of the TAZ FL and the Δ5 isoforms reversed gene expression to a larger extent. Moreover, only rat full length TAZ was able to reverse proliferation rate. Surprisingly, the expression of Δ5 in C6 TAZ cells did not promote proliferation of the wild type. Different effects of Δ5 and FL on CL composition and cell proliferation points to the specific and in part non-enzymatic functions of tafazzin isoforms, but this certainly requires further analysis.